Medical device firm backed by Wisconsin investors gains FDA approval


The FDA gave HistoSonics market authorization for its Edison device, which destroys liver tumors with sound waves.

Previous ACI Worldwide agrees to pay $10M to states over claim that technical error caused unauthorized withdrawals of loan holders
Next Procter & Gamble agrees to consolidation of industry-wide lawsuits against DayQuil, other decongestants